Alexander Quaas

29PUBLICATIONS
137CO-AUTHORS
Predictive and prognostic markersNeurology and neuromuscular diseasesMolecular targetsGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Aug 12, 2026
Sex-Specific Proteomic Profiling Identifies Pregnancy Zone Protein as a Complement-Linked Marker of Adverse Prognosis in Esophageal Adenocarcinoma.

|Aug 03, 2026
Distinct enteric nervous system pattern in obstructed defecation syndrome and slow-transit constipation: a controlled digital pathology study.

|Jul 08, 2026
Proteomic characterization of SMARCA-deficient esophageal adenocarcinoma reveals complement evasion and DNA repair-associated prognostic subgroups.

|Jul 03, 2026
MET Expression in Upper Gastrointestinal Adenocarcinoma: Prevalence, Prognostic Impact, and Implications for Anti-MET Antibody-Drug Conjugate Therapy.

|May 14, 2026
Health-related quality of life comparing standard and prolonged time-to-surgery after neoadjuvant chemoradiotherapy for esophageal cancer: results from the multicenter, randomized, controlled NeoRes II trial.

|Apr 07, 2026
ADC Target Profiling in NSCLC: Generalizable AI Separates TROP-2 and cMET Phenotypes.

Philipp Anders, Marvin Sextro, Katja Lingelbach

Pageof 5

Frequent Collaborators

6 joint publications

Reinhard Büttner

6 joint publications

Georg Schlachtenberger

5 joint publications

Su Ir Lyu

5 joint publications

Fabian Doerr